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Abstract.  The cDNA for a previously described 
growth inhibitor, designated as mammary-derived 
growth inhibitor (MDGI) (Grosse, R., and P. Langen. 
1989. In Handbook of Experimental Pharmacology. In 
press) has been cloned from a plasmid library which 
was derived from terminally differentiated bovine 
mammary gland. 
Sequencing of the cDNA showed an open reading 
frame coding for a protein of 133 amino acids. In six 
positions differences were found between the sequence 
determined from the cDNA and that determined previ- 
ously by amino acid sequence analysis. Northern blot 
analysis revealed abundant MDGI mRNA in the termi- 
nally differentiated mammary gland, whereas in virgin 
gland, liver or pancreas transcripts were not ex- 
pressed. By use of in situ hybridization technique 
transcription of MDGI in the developing bovine mam- 
mary gland was analyzed. 
Increasing amounts of MDGI mRNA were detected 
in the epithelial cells of embryonic mammary rudi- 
ment, in the epithelium of developing lobules and in 
terminal parts of ducts and lobuloalveolar epithelial 
cells of differentiated glands. There was a geographical 
gradient of MDGI mRNA concentration in bovine 
mammary gland reaching a maximum in the proximal 
parts of the tissue. An immunohistochemical analysis 
with different polyclonal and peptide directed antibod- 
ies against MDGI confirmed the in situ hybridization 
data with respect to the tissue-specific and 
differentiation-dependent MDGI expression in bovine 
mammary gland. The results suggest a close relation- 
ship between MDGI transcription and developmental 
processes in the normal bovine mammary gland. 
D 
VELOPMENT and differentiation of mammary tissue 
is driven by a combination of hormonal and local 
controls (17, 22, 30, 57, 58). In vitro studies with or- 
gan cultures (19, 45, 56, 62) and with mammary epithelial 
cells growing  either within collagen  gels (27, 49)  or as 
monolayers (2, 31) identified the importance of steroid hor- 
mones and polypeptide growth factors for glandular mor- 
phogenesis and differentiation. 
In virgin animals mammary gland morphogenesis stops at 
an  immature state characterized by preformed branching 
ducts terminated by stem cell populations with the property 
to form during pregnancy Iobuloalveolar epithelial and myo- 
epithelial  cells (18, 27).  During pregnancy the ductal tree 
undergoes growth and differentiation culminating in a func- 
tionally  specialized  lobuloalveolar  gland capable  of milk 
synthesis and secretion. Little is known about the regional 
and developmental expression of locally acting growth fac- 
tors and growth inhibitors  in this periodically regenerating 
epithelium. Knowledge of the expressional pattern of growth 
factors potentially  involved in mammary development and 
differentiation may be useful for better understanding of nor- 
mal and neoplastic growth. 
Among the known polypeptide growth factors most studies 
have been devoted to EGF for mammary development. Al- 
though a  local  synthesis and expression  in the mammary 
gland has not been shown the mitogenic activity of EGF-like 
factors seems necessary for growth and development of the 
epithelium  (22,  32, 55¢56,  59). 
The existence of growth inhibitory  polypeptides control- 
ling growth, differentiation, and regression of the epithelium 
in vivo has been postulated  (22, 24, 39). For transforming 
growth factor beta, which inhibits proliferation and lobuloal- 
veolar outgrowth in the mammary gland of virgin mice, a 
similar role was discussed  (53). 
More recently a  protein called mammastatin has been 
purified from conditioned media of normal mammary epi- 
thelial cells. This polypeptide blocks DNA synthesis in cul- 
tured normal and transformed mammary epithelial cells and 
is secreted by the same cells (20). 
Another protein involved in growth inhibition has been de- 
scribed by us (8). A 13-kD growth inhibitor, designated mam- 
mary-derived growth inhibitor (MDGI) t has been purified 
1,  Abbreviations  used  in  this paper:  FABP,  fatty  acid  binding protein; 
MDGI,  mammary-derived  growth  inhibitor;  PCR,  polymerase  chain 
reaction. 
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globule membranes (11). MDGI reversibly inhibits the pro- 
liferation of several normal and transformed mammary epi- 
thelial cells in vitro (7, 8, 24). The inhibitor shares extensive 
sequence similarity to a family of proteins with the common 
feature to bind hydrophobic ligands such as retinoic acid or 
fatty acids (6,  8). 
To  gain  further  insights  into  the  spatial  and  temporal 
MDGI expression during mammary gland development we 
have used a cloned eDNA and different anti-MDGI antibod- 
ies to investigate the tissue specific and cellular distribution 
of this growth inhibitor. The results clearly show that MDGI 
is  transcribed  in  mammary  epithelial  cells of developing 
lobuloalveolar  structures  reaching  abundance  in proximal 
parts  of the terminally  differentiated gland.  Striking  RNA 
concentrations were found in the terminal parts of differen- 
tiated ducts. The level of MDGI mRNA parallels the appear- 
ance of the protein it encodes thus suggesting a transcrip- 
tional  control  of  MDGI  expression  during  mammary 
development. 
Materials and Methods 
Synthesis of the Bovine Mammary Gland 
cDNA Library 
RNA  was isolated from lactating bovine mammary gland according to 
Chomczynsky and Sacchi (14).  FOly (A)-containing mRNA was prepared 
by chromatography on Poly (U)-Sepharose (Pharmacia, Uppsala, Sweden) 
and complementary DNA was synthesized according to Gubler and Hoff- 
man (25) with the modifications introduced by the Amersham Corp. (Ar- 
lington Heights, IL) eDNA synthesis kit. The eDNA was ligated into the 
Hinc II site of pUC  19 (43) and transformed into Escherichia coil DH5a 
yielding a library of 3  x  l05 independent clones. 
Polymerase Chain Reaction 
Polymerase chain reaction (PCR) was performed as described (48).  10 ng 
of the bovine mammary gland double°stranded eDNA or 2  #g genomic 
DNA in 0.1 ml PCR-buffer consisting of 50 mM KCI,  I0 mM Tris-HCl, 
pH 8.3,  1.5 mM MgCI2, 0.1 mg/ml gelatine, 4 ~M each of the different oli- 
gonucleotide PCR primers (At, A2, Bt, and B2, described in the following 
section), 200/tM each of dATP,  dTTP, dCTP, dGTP, and 2  U Thermus 
auquaticus DNA polymerase (Perkin Elmer Cetus Instruments) were over- 
laid with 100/~1 of liquid paraffin to prevent evaporation. Each of the 30 
cycles of PCR consisted of incubations at 95°C for 1 min, at 50°C for 2 
rain, and at 72°C for 2 min except that the last extension period was for 
7 rain. 
Screening of the cDNA Library 
Approximately 80,000 bacterial colonies were screened with a DNA probe 
amplified from the lactating bovine mammary gland eDNA by PCR. First, 
a fragment of the bovine mammary gland cDNA was amplified by using de- 
generated oligonucleotide primers that were synthesized according to the 
MDGI protein sequence (8).  Sequences of the primers are 5' CAAGCT- 
TAAQTTQGAQGAQTAQATQ 3' designated as At and 5' GC_~AATTQI'G- 
NCCPTTCCAQI'TQ'I~ 3' designated as A2 corresponding to amino acids 
at positions 16-21  (A0 and 97-101 (A2) of the described MDGI sequence. 
The oligonucleotides include additional restriction endonuclease sites for 
Hind III (A0 and Eco RI (A2) to facilitate ligation. The amplified fragment 
of 258 bp was isolated, cleaved with Eco RI and Hind IIl and cloned into 
pUC 19 for sequence analysis. The DNA probe was labeled by the random 
hexanucleotide primed synthesis method (21) resulting in specific activities 
of 1 x  109 cpm//tg of DNA. Colony hybridization was performed under 
low stringency conditions at 58°C in 500 mM NaHPO4, pH 7.2,  1 mM 
EDTA, 1% SDS, 0.5% dry milk powder for 18 h. Duplicate nitrocellulose 
filters were washed three times for 20 rain each in 0.1% SDS, 2x  SSC at 
50°C. (lx  SSC: 0.3  M  NaCI, 0.03  M  sodium citrate, pH 7.4). 
Dot Blot A nalysis 
By use of the primers 5' CAAGCTTGTNGAQGCNTTQGTN  3' and 5' 
GC~AATTCKATNACNGTPTCQCC 3' (designated as Bt and B2, coding 
for  residues 2-6  and 46-51,  respectively) a  MDGI  fragment spanning 
amino acids 2-51  was amplified from both eDNA and genomic DNA by 
PCR. To this end 5/~1 of each of the DNA amplified in vitro was spotted 
onto nitrocellulose filters. Oligonucleotide probes designated as SE, DK, 
LS, or TE that are either derived from the eDNA sequence (DK, TE) or 
from the protein sequence for MDGI (SE, LS) were used. The filters were 
soaked successively in 0.5 M NaOH, then in 1 M Tris, pH 8.0, and finally 
in 0.5 M Tris, pH 8.0, 1.5 M NaCI. Filters were baked for 2 h at 80°C under 
vacuum. For hybridization, the filters were prehybridized for 16 h at 52°C 
(for hybridization with TE/LS) and at 43°C (for hybridization with DK/SE) 
in 3.0  M  tetramethylamrnonium chloride, 50 mM "Iris,  pH 8.0,  2  mM 
EDTA, 100/~g/ml of sonicated, denatured salmon sperm DNA, 0.1% SDS, 
and 5 x  Denhardt's solution. Hybridization conditions were chosen to detect 
single base mismatches (10, 40). Approximately 100 lag of 32p-labeled oli- 
gonucleotide probe (sp act 109 cpm//~g) were added to nitrocellulose filters 
and hybridization was performed for 1 h  at 43°C (DK/SE) or at 52°C 
(TE/LS), respectively. The filters were washed in 2x  SSC, 0.1% SDS for 
5 min at room temperature, followed by a 5-min wash at 45°C for (DK/SE) 
and at 54°C for (TE/LS) in 5x  SSC, 0.1% SDS. Subsequently the filters 
were washed twice in hybridization buffer without Denhardt's solution and 
salmon sperm DNA and then incubated for 1 h in the same solution at 43°C 
for (DK, SE) and at 53°C for (TE, LS). 
DNA Sequence Analysis 
DNA from positive clones derived from the cDNA library or from the am- 
plified and cloned PCR fragments was sequenced in both directions by the 
dideoxy chain-termination method (50),  adapted for plasmid sequencing 
(12). Restriction fragments from each plasmid were snbeloned for sequenc- 
ing in MI3 mpl8 and mpl9 Phage (43). 
Northern Blot Analysis 
Equal amounts of total cellular RNAs, isolated as described (14) were sub- 
jected to Northern blot analysis (36). The Northern blots were probed with 
the complete 681-bp eDNA fragment. Labeling and hybridization condi- 
tions were the same as for colony screening except that the washing temper- 
ature was 60°C. The relative intensity of hybridization signals in Northern 
blotting was estimated using a Shimadzu scanning densitometer. 
In Situ Hybridization 
The complete MDGI eDNA was subcloned in pGEM 3Z (Promega Biotech, 
Madison, WI). After linearizing the plasmid pGEM/MDGI with Hind III 
the insert was transcribed in vitro ,with T7  polymerase yielding a  35S- 
labeled antisense RNA probe with a specific activity of l09 cpm//zg. Bo- 
vine mammary tissue at different stages of development was collected and 
stored frozen until sectioning. Gammaoaminopropyltriethoxysilane (Sigma 
Chemical Co., St. Louis, MO) coated slides we're used to lift 6-#m cr~stat 
sections which were then fixed in freshly prepared 4% paraformaldebyde 
for 1 rain and dehydrated in 70% ethanol. Hybridization was performed at 
standard conditions (41) with the following modifications. Prebybridizati0n 
treatment consisted of rehydration of the sections in 2x  SSC, acetylation 
in 0.25% acetic anhydrate, 0.1 M triethanolamine, pH 8.0, followed by im- 
mersing the slides for 30 min in 0.1 M Tris-HCl, pH 7.0, 0.1 M  glycine. 
After rinsing the slides in 2x SSC and an incubation in 2x SSC, 50% for- 
mamide at 55°C for 5 rain, the sections were finally hybridized in a solution 
composed of2x SSC, 50% formamide, 10% dextran, 10raM DTT,  1 #g/ml 
E. coil tRNA, l p,g/ml sheared herring sperm DNA, 2/.tg/ml BSA, and 1 
x  106 cpm of 35S-labeled RNA probe at 50°C for 3 h. The slides were then 
washed in 2x  SSC, 50% formamide at 52°C for 30 min with three buffer 
changes, rinsed in 2x  SSC, and then incubated in RNase solution (100 
#g/ml RNase A, 1/.tg/ml RNase T1) at 37°C for 30 min. After final washes 
in 2x SSC, 50% formamide at 52°C for 5 rain, and 2x SSC at room tem- 
perature for 10 min, sections were dehydrated in 70, 80, and 90% ethanol. 
Hybridization of the tissue sections of the lactating mammary gland with 
the same amount of anfisense 35S-labeled RNA probes for the PDGF A-chain 
did not show any positive signal. Furthermore, if sections were pretreated 
with RNase solution before hybridization, no signal was detected. Sequen- 
tial sections were also hybridized with an antisense/3-actin RNA probe; 
positive signals were obtained, indicating the presence of intact RNA in the 
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track emulsion (Kodak Laboratory and Specialty Chemicals, Eastman Ko- 
dak Co., Rochester, NY) melted at 43°C and diluted 1:1 in water. The slides 
were exposed for 4-5 d in the dark at 4°C, and were then developed and 
counterstained with hematoxyline and cosine, dehydrated, mounted, and 
covered with coverslips. 
lmraunohistochemistry 
Cryostat sections used for immunohistochemistry were stored at  -200C 
and fixed in cold acetone for 10 min just before use. Sections were prein- 
cubated with normal goat serum, then reacted with affinity-purified rabbit 
anti-MDGI-IgG (42) and stained by the ABC-technique using a biotinylated 
secondary antibody and preformed avidin and biotinylated horseradish per- 
oxidase complex according to reference 29. 
Normal rabbit serum was used as a negative control. Immunostained sec- 
tions  were  photographed after  hematoxyline  staining  with  bright  field 
optics. 
Preparation of  Antibodies 
An affinity-purified anti-MDGI-IgG and an antibody directed against the 
peptide EFDETTADDR  corresponding to amino acids 69-78 of MDGI 
(designated as anti-p69/78-IgG) has been described earlier (42). A second 
peptide antibody, anti-pl21/131-IgG was obtained as follows. The peptide 
TAVCTRVYEKQ,  corresponding to amino acids  121-131 of MDGI,  was 
synthesized (42), reduced by fl-mercaptoethanol and passed over Sephadex 
GI0. BSA, activated by iodoacetamide in the presence of N-succinimidyl- 
bromo-acetate (4), purified by gel chromatography on Sephadex G25 M, 
was then conjugated with the reduced peptide under stirring for 2 h at room 
temperature. The conjugate was dialyzed against PBS (20 mM sodium phos- 
phate,  150 mM NaCI, pH 7.4) at 4°C and then injected into rabbits. The 
resulting antiserum was purified by affinity chromatography on MDGI cou- 
pled to CNBr-activated Sepharose CL-4B (Pharmacia) as described (42). 
Western blot experiments were performed as described earlier (7). 
Electron Microscopy 
The procedure which has been described earlier (42) was slightly modified. 
Ultrathin sections from Lowicryl K4M embedded tissue were collected on 
formvarcarboni:oated copper grids and were floated first on droplets of TBS 
supplemented with 16-48 #g/ml antibodies. For reducing the background 
the concentration of NaCI was increased to 500 mM and the washing buffers 
were supplemented with 0.1% BSA and 0.05 % Tween 20. After washing five 
times for 2 min they were incubated for 30 min with protein A conjugated 
with gold particles (diameter 15 nm), (diluted with TBS/BSA to an absor- 
bance of 0.04 at 525 nm). 
The specificity of  the labeling procedure was determined  by replacing the 
different antibodies against MDGI by (a) TBS/BSA, (b) preimmune rabbit 
IgO, (c) "flow through'-IgG from a MDGI affinity column, and (d) anti- 
MDGI-IgG preadsorbed with MDGI.  Immunoreactive staining was abol- 
ished under these conditions. Labeled ultrathin sections were convention- 
ally poststained with uranyl acetate and lead citrate. Electron micrographs 
were taken with an EM 4001" (Philips) at an acceleration voltage of 80 kV. 
Results 
Nucleotide Sequence of  MDGI cDNA 
Starting from the eDNA synthesized from RNA of lactating 
mammary gland a  MDGI-specific probe was amplified by 
PCR. Amplification with degenerated oligonucleotide pri- 
mers complementary to amino acids 16-21  (At) and 97-101 
(A2), which were deduced from the MDGI protein sequence, 
generated a 258-bp fragment. Sequence analysis showed that 
this fragment codes for the anticipated amino acids 16-101 
of the reported MDGI amino acid sequence. However, at po- 
sition 41 Leu was exchanged for Thr, a Set was exchanged 
for Glu at position 44, and Gin was substituted by His at po- 
sition 94.  The bovine mammary gland eDNA library was 
then probed with this fragment under low stringency condi- 
tions. Nine eDNA clones were isolated and all of the nine 
isolated clones showed an insert length of",,680 bp. Nucleo- 
tide sequence analysis revealed identical sequences for all 
clones (Fig.  1). Translation of the compiled nucleotide se- 
quence disclosed an initiation codon that begins at position 
38 followed by an open reading frame that terminates with 
a TGA terminator codon at nucleotide 437. The 133 residues 
long polypeptide encoded by this region has a calculated mo- 
lecular weight of 14,673. The ATG initiation site is integrated 
in the consensus sequence CCRCCATG proposed for eucary- 
otic translation initiation (35).  The 3' untranslated region 
spans 235 nucleotides including a consensus AATAAA poly- 
adenylation signal 14 nucleotides upstream of the poly (dA)- 
tail. The open reading frame codes for most of the amino 
acids reported in the published sequence for MDGI (8) al- 
though differences were found at six positions. In positions 
M  V  D  A  F  V  G  T 
TTCTC[GTCGTC[TrCCCAACC[AGCCCAGCTTCACC  ATG  GTG  SAC  GCC  TTC  GTG  GGT  ACC 
W  K  L  V  D  S  K  N  F  D  I)  Y  M  K  S  L  G  V  G 
FGG  AAG  TFA  GTG  SAC  AGC  AAG  AAT  TTC  SAT  SAC  FAC  AFG  AAG  TCA  C[C  GGT  GTC  GGT 
F  A  T  R  (}  V  G  N  M  T  K  P  T  T  I  I  E  V  N 
TTT  BCT  ACC  AGG  CAG  GTG  GBC  AAT  /~TG ACC  AAB  CCT  ACC  ACA  ATC  ATC  GAA  GTG  AA3 
G  D  T  V  I  I  K  T  Q  S  T  F  K  N  T  E  I  S  F 
GBG  BAC  ACA  GTC  ATC  ATA  A~A  ACA  CAA  AGC  ACC  TTC  AAG  AAC  ACA  GAG  ATC  (~GC TIC 
K  L  G  q  E  F  D  E  T  T  A  (}  D  R  K  V  IK  S  [ 
AAG  CTG  ~GA  GTC  GAG  TIC  GAT  GAG  ACC  ACA  BCA  GAT  SAC  ASS  AAA  GTC  AAG  TCC  ATE: 
@ 
V  T  L  D  G  G  K  L  V  H  V  Q  K  N  N  G  Q  E  X 
GT6  ACG  CrG  SAT  GGC  GGC  AAA  CTT  GTC  CAC  GTG  CAG  AAG  TGG  AAI" GGA  CAA  GAG  ACA 
S  L  V  R  E  M  V  D  B  K  L  I  L  T  L  T  H  G  T 
TCA  CTT  GTG  CGG  GAA  A~'G GTT  GAC  GGG  AAA  CTC  AT[  CFG  ACA  CTC  ACC  CAT  GGC  ACT 
A  V  C  T  R  T  Y  E  K  Q  A 
GCA  GTT  TGC  ACT  CGT  ACT  TAC  GAG  AAA  CAB  GCA  TGACCTGCCCTCTCCTTCCACTGACTBCTCT 
TCTGCCAGTGGGCTACTCCTGGACTCGGCACCAGATTGCCTCATTTTTC[CCTCTGGCATTTTGTATAA~TCCAC 
CTTGACTGGGGAAATICTCCTGGBGTCAGBTGGCACCAGCCTGGATCCAGTTCCG~TCTCATTGTGTCTGTTIGT 
TTTTTTAACTGCATCCAAAGGGTGCTCTGAGGTC~ATAAAGCAGASCCAAGGCCAAAAAAAAA 
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Figure 1. Nucleotide and deduced amino acid se- 
quence of MDGI eDNA. Residues that are super- 
lined correspond to the amplified fragment used as 
screening probe.  The nucleotide sequence under- 
lined at the beginning of the open reading frame 
represents the eucaryotic translation initiation con- 
sensus sequence. The polyadenylation signal in the 
3' nontranslated region is also underlined. Amino 
acids that are not identical  with those of the re- 
ported MDGI sequence are labeled by asterisks. 
These sequence data  are available  from EMBL/ 
GenBank DDBJ under accession number X51933. 
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instead of Leu and Ser, which were found in amino acid se- 
quence analysis. The other differences at position 13 (Asp for 
Ser),  15 (Lys for Glu), 94 (His for Gin), and 128 (Thr for 
Val) represent ambiguous determinations in the reported pro- 
tein  sequence,  where the amino acids predicted from the 
cDNA sequence were also found, but at lower yield (8). The 
Met residue at position 1 and the Ala at position 133 of the 
cDNA deduced sequence were not found by protein sequenc- 
ing and are possibly removed by posttranslational  protein 
processing. 
Dot Blot Analysis for MDGI Sequence Variants 
To investigate the possible appearance of nonabundant cDNA 
species coding for MDGI the approach of selective hybrid- 
ization with a  collection of synthetic oligonucleotides was 
chosen (Fig. 2). To this end PCR was performed with pri- 
mers constructed to amplify fragments corresponding to the 
cDNA-dedueed MDGI structure or to fragments containing 
putative exchanges in positions 13, 15, 41, or 44. DNA frag- 
ments overlapping amino acids 2-51 of MDGI were ampli- 
fied from cDNA of two separate bovine mammary glands 
(Fig.  2, a  and b) and from bovine genomic DNA of three 
different animals (Fig. 2, c-e). 5 #1 aliquots of the amplified 
DNA samples were spotted on nitrocellulose and hybridized 
with oligonucleotide probes; probes DK and TE coded for 
amino acids VDSKN and TTIIEV, respectively, and were 
derived from the cDNA sequence, and probes SE and LS 
corresponded to amino acids VSSEN and TLIISV, respec- 
tively, which were determined by amino acid sequence anal- 
ysis. Each of the peptides contain two amino acid exchanges 
generating at least two base pair exchanges between DK/SE 
and four between TE/LS. Hybridization was performed un- 
der conditions where only completely matched hybrids re- 
main stable. Under these conditions, only the oligomers DK 
and TE that are complementary to the described cDNA se- 
quence, hybridized with the amplified DNA. No hybridiza- 
tion was  obtained with the oligomers SE and  LS derived 
from the protein sequence. 
Northern Blot Analysis 
To determine the relative level of MDGI mRNA in different 
bovine tissues and in bovine mammary glands of different 
functional state a Northern blot analysis using the complete 
MDGI cDNA was performed (Fig. 3). A transcript of 0.7 kb 
was detected in the mammary gland of midpregnant (Fig. 3 
b), and lactating animals (Fig. 3 c), in heart muscle tissue 
(Fig.  3  e),  and  in  skeletal  muscle  (Fig.  3  g).  No  MDGI 
mRNA was found in liver (Fig. 3f) and pancreas (Fig. 3 h). 
The MDGI mRNA level in mammary gland depends on 
the developmental stage of  the tissue. In virgin mammary tis- 
sue MDGI mRNA is not present (Fig. 3 a), its level increases 
during pregnancy (Fig. 3 b) reaching a maximum at lactation 
(Fig. 3 c). From densiometry the increase of MDGI mRNA 
was fivefold at lactation in comparison to pregnancy. Also, 
there is a  geographical gradient of MDGI mRNA starting 
from a  high  concentration  in  proximal  parts  of lactating 
mammary tissue (Fig.  3  c) and declining to zero in distal 
parts (Fig. 3 d). 
Localization  of  MDGI Gene Transcription  in the 
Mammary Gland by In Situ Hybridization 
Based on the findings that transcription of MDGI is related 
to the proliferative state of mammary gland,  cryosections 
were analyzed for MDGI mRNA using in situ hybridization 
technique. The results obtained with a asS-labeled  antisense 
RNA probe are summarized in Figs.  4  and 5. 
To follow MDGI transcription during development tissue 
sections were taken from embryonic, virgin, pregnant, and 
from different areas of lactating mammary gland. Analysis 
of a 5-mo-old female bovine embryo revealed clearly detect- 
able transcripts in the manunary epithelial rudiment (Fig. 4, 
A and B). MDGI mRNA is evenly distributed with similar 
amount over the distal and proximal regions. Mesenchymal 
Figure 2. Dot blot analysis of amplified MDGI sequences. The amplification of MI)GI fragments by PCR is shown in A. eDNA from 
two distinct animals (a and b) and genomic DNA from three bovine breeds (c-e) were used to amplify a fragment of 150 bp. Sequence 
analysis proved this fragment to code for amino acids 2-51 of reported MDGI amino acid sequence thus confirming the MDGI eDNA. 
Dot blot analysis of the amplified DNA samples is shown in B. Analysis was performed by use of oligonucleotide probes either hybridizing 
specifically with the MDGI eDNA sequence (DK, TE) or with the MDGI protein-derived sequence (SE, LS). Oligonueleotides DK and 
SE are spanning the region between amino acids 12-16 and oligonucleotides TE and LS the region between amino acids 40 and 45 of 
MDGI. Each region contains two amino acid differences. About 50 ng of the amplified fragment were spotted on nitrocellulose and hybrid- 
ized to the oligonucleotide probes for detection of single base substitutions. An autoradiogram of filters exposed for 4 h is shown. No 
signal could be detected with the probes SE and LS, even after 1 wk of autoradiography. 
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tion was performed with the complete MDGI eDNA. Blots were 
prepared with total cellular RNA (20 #g) from virgin mammary tis- 
sue (a), pregnant mammary tissue (b), central parts of lactating 
mammary tissue (c), peripheral parts of lactating mammary tissue 
(d), heart (e), liver (f), red skeletal muscle (g), and pancreas (h). 
Exposure time, 48 h. 
tissue was  not labeled by the antisense RNA probe  (not 
demonstrated). In the immature, resting mammary gland of 
the virgin animal, MDGI mRNA was not detected (Fig. 4 
C). The bovine mammary gland in the fifth month of preg- 
nancy  is  undergoing  deep  morphological  and  functional 
changes (Fig. 4, D and E). In Fig. 4 D a branching duct is 
shown which terminates with developing lobuloalveoli. Dur- 
ing this stage of development ductal and alveolar epithelial 
cells in combination with myoepithelial cells are forming the 
lobuloalveolar gland.  In the ductal epithelial cells, MDGI 
transcription was rather low while epithelial cells of  develop- 
ing alveoli contained MDGI transcripts. Analysis of a de- 
veloping lobulus at higher magnification clearly shows that 
MDGI transcription is enhanced in the alveolar cells when 
compared to ductal epithelial cells (Fig. 4 F). Closer analy- 
sis of the lobuloalveolar gland of the pregnant animal re- 
vealed an increased MDGI mRNA level in the alveolar epi- 
thelial cells bordering on the connective tissue (not shown). 
Other cell types such as myoepithelial cells and connective 
tissue were not transcribing MDGI. 
The terminally differentiated lactating mammary gland is 
characterized by ducts branching into large secretory active 
lobuloalveolar structures (Fig. 5, A-C). In contrast to the 
pregnant stage both the alveolar (Fig. 5, A and B) and ductal 
cells (Fig. 5 C) of terminally differentiated mammary gland 
transcribe the MDGI gene. Along the duct, a striking in- 
crease  in  the  level  of MDGI transcripts  was  found with 
highest levels in the terminal part (Fig.  5  C).  In general, 
MDGI mRNA was clearly expressed at higher levels in the 
ductal epithelial cells compared to the alveolar mammary 
epithelial cells. Other cell types such as fibroblasts and myo- 
epithelial cells were not found to transcribe the MDGI gene. 
MDGI transcription follows a geographical gradient; in the 
less differentiated distal parts of lactating mammary gland 
(Fig. 5 D) including the nipple of the mammary gland (Fig. 
5 E) MDGI mRNA was clearly reduced. During all stages 
of  diff rentiafion MDGI protein expression parallels the MDGI 
mRNA level. For example, Fig. 5 F  shows an immunohis- 
tochemical analysis of MDGI expression by using an affinity- 
purified rabbit anti-MDGI antibody. The picture also shows 
secretion of MDGI. 
Immunohistochemical Analysis of  MDGI Distribution 
in the Mammary Gland 
Specificity of  Antibodies.  A high speed supernatant of a ho- 
mogenate of lactating bovine gland was subjected to SDS- 
PAGE and immunoblotting (Fig.  6).  A  single band corre- 
sponding to an antigen of 14.5  kD was identified with the 
purified polyclonal anti-MDGI-IgG, as well as with anti- 
p69/78-IgG, an antiserum made against a peptide compris- 
ing amino acids 69-78,  and with anti-pl21/131-IgG,  made 
against a peptide comprising amino acids 121-131. Preincu- 
bation of the antibodies  with an excess of MDGI led to 
quenching of the staining of the 14.5-kD band, indicating 
that the reactions were specific. 
lntraceUular Distribution of  MDGI in Mammary Gland 
of Different  Functional  State.  Lowicryl-embedded ultra- 
thin sections taken from virgin, pregnant, and lactating bo- 
vine mammary gland were analyzed by means of the im- 
munogold technique using afffinity-purified anti-MDGI-IgG. 
An increasing density of immunolabeling was detected over 
resting, proliferating, and differentiated mammary epithelial 
cells (Fig. 7), which is in accordance with the MDGI mRNA 
levels determined before in the same tissues. In the virgin tis- 
sue MDGI was not expressed (Fig. 7 A), a moderate intensity 
of immunolabeling was found during pregnancy (Fig. 7 B), 
reaching a maximal level during functional differentiation  of 
the mammary gland (Fig. 7  C). 
Immunolabeling of mammary epithelial cells was associ- 
ated with basal invaginations, the cytosol, and the transcrip- 
tionally active euchromatic regions of nuclei. Other cell com- 
partments  such  as  mitochondria  and  rough  endoplasmic 
reticulum were not labeled. A very similar though less in- 
tense staining pattern was observed with the two antisera 
against peptides of MDGI (Fig. 7, D and E). Some preferen- 
tial nuclear labeling was observed with the antibody directed 
against  the  COOH-terminal  amino  acids  121-131 of the 
MDGI sequence (Fig. 7 E). 
Discussion 
In this communication we report on the cDNA cloning for 
MDGI and the developmental expression of MDGI mRNA 
in bovine mammary gland. On the basis of amino acid se- 
quence analysis we have shown earlier that MDGI belongs 
to a family of structurally related proteins, consisting of fatty 
acid binding proteins (1, 6, 15, 44), cellular retinoid binding 
proteins (13, 37), myelin P-2, and an adipose differentiation 
dependent protein, called P422 (5, 34, 38). MDGI is also im- 
munologically related to a  fibroblast growth inhibitor (9). 
The amino acid sequence deduced from the cDNA sequence 
and the protein-derived amino acid sequence differ in six po- 
sitions, not taking into account a NH2-terminal methionine 
and a COOH-terminal alanine which are thought to be re- 
moved by posttranslational modification. 
In each of  positions 12, 14, 93, and 127 protein sequencing 
yielded two amino acid residues (8). At these positions the 
cDNA-deduced residues correspond to the amino acids pres- 
ent at lower yield. Two additional differences were detected 
at positions 40 and 43, where the MDGI cDNA predicts Thr 
and Gin instead of Leu and Ser, respectively. The differences 
might have arisen from genetic polymorphism of the ani- 
mals, although mutations in the intraspecies variant between 
Kurtz et al. MDGI Expression in the Mammary Gland  1783 Figure 4.  Distribution of MDGI RNA in embryonic, virgin, and pregnant mammary tissue. MDGI transcripts were detected by in situ 
hybridization, using cryostat sections hybridized with 3sS-labeled antisense RNA probe. Shown are bright-field and dark-field pictures of 
sections counterstained with hematoxyline. (A and B) Sections of mid stage mammary epithelial rudiment; MDGI transcripts are evenly 
distributed in epithelial cells of the embryonic mammary rudiment. (C) Virgin mammary gland; no MDGI transcripts are detectable. (D 
and E) Longitudinal sections of midpregnant mammary gland. This picture shows the terminal part of a duct where lobuloalveolar  structures 
are developing. (F) Higher magnification of a part of section shown in D. Epithelial cells of the lobuloalveoli  are expressing MDGI mRNA 
at this early stage of development. In contrast, epithelial cells of the duct are not labeled. Bars,  100/~m. 
The Journal of Cell Biology,  Volume 110, 1990  1784 Figure 5. Distribution of MDGI mRNA in terminally differentiated bovine mammary gland. (A) Cross section of proximal part of lactating 
mammary tissue; (B) dark-field picture of A; (C) longitudinal section of tissue in the same developmental stage as in A; (D) distal part 
of the same lactating mammary tissue; and (E) section of the nipple of the same tissue. (F) Section of tissue shown in A stained by the 
ABC method with affinity-purified polyclonal anti-MDGI IgG. Bars,  100 t~m. 
the two residues would have required the replacement of four 
bases in the codons. Moreover, including RNA preparations 
from different animals, both screening under low stringency 
conditions of the cDNA bank, followed by sequence analysis 
of nine clones, and dot blot analyses of fragments amplified 
from either cDNA or genomic DNA did not reveal any poly- 
morphism. Nevertheless, the techniques used in the present 
paper do not rule out the possibility that slightly different 
forms of MDGI exist in the mammary gland. In this regard, 
several reports have discussed multiple forms of fatty acid 
Kurtz et al. MDGI Expression  in the Mammary Gland  1785 Figure 6. Specificity  of  anti-MDGI-antibodies.  A high speed super- 
natant of a homogenate  from lactating bovine mammary gland was 
subjected to SDS-PAGE. Immunoreactive  bands were detected by 
immunoblotting  and stained using anti-MDGI-IgG  (lanes a and b), 
anti-p69/78-IgG (lanes c and d), and anti-pl21/131-IgG  (lanes e and 
f).  Controls were immunostained with anti-MDGI-IgG pread- 
sorbed with MDGI (lane b),  with anti-p69/78-IgG preadsorbed 
with MDGI (lane d), and with anti-pl21/131-IgG  preadsorbed with 
MDGI (lane f). 
binding proteins (FABPs) in heart (15, 28, 34, 44, 47), intes- 
tine (1, 3), liver (26, 54), and mammary gland (8, 33, 61). 
For the bovine heart FABP (6) two isoforms were found 
which differ by one exchange (Asn for Asp at position 98) 
from each other. We also have detected at least two MDGI- 
forms in bovine mammary gland differing in their isoelectric 
points (Bfhmer, E-D., unpublished results). Whether these 
forms are coded by different genes is not known. Chromo- 
some mapping study revealed that the murine genome con- 
tains at least three loci located on different chromosomes 
which  hybridize with a  cloned heart  FABP cDNA  (60). 
Whether these loci represent pseudogenes or transcribing se- 
quences of homologous proteins could not be determined. 
The cDNA-deduced MDGI sequence is identical with that 
reported for the bovine heart FABP (6).  Thus, the MDGI 
mRNA is expressed in heart tissue. The exact function Qf 
FABPs is not yet identified. It has been suggested that in the 
heart, FABP regulates the supply of fatty acids to the mito- 
chondria for beta-oxidation (3,  6).  The mammary gland, 
however, is a highly lipogenic tissue and fatty acids are not 
likely to  he a  major  fuel  for its  metabolism.  Therefore, 
MDGI could fulfill different functions in heart and in mam- 
mary gland. The functional meaning of heart muscle related 
FABPs in brain (3, 28, 51) and kidney (3,  15) is for similar 
reasons difficult to understand. It is possible that different 
forms of FABPs and MDGI fulfill several unrelated func- 
tions, including growth inhibition. In this regard, it has been 
established recently that some FABPs are expressed in a 
differentiation  dependent manner (16, 46, 52, 54). For cellu- 
lar retinoic acid binding protein (13, 19, 37) and P422 (5) this 
was described earlier. It seems clear that a differentiation  as- 
sociated function is a common property of these structurally 
related proteins. For example, expression of  the rat intestinal 
FABPs shows a distinct gradient from the proximal to the 
distal intestine and from crypts to villus tips (23, 54). The 
authors conclude that the FABP gene products are sensitive 
indicators of differences in  fetal  intestinal  epithelial  cell 
differentiation (23). 
Similar to the expression of intestinal FABP, MDGI tran- 
scription follows a geographical gradient with higher mRNA 
levels towards the proximal glandular tissue. There was a 
distinct difference in expression in midpregnant and termi- 
nally differentiated tissue. During midpregnancy, when the 
mammary epithelium undergoes  deep  functional changes 
and lobuloalveolar structures emerge, MDGI transcription 
was mainly restricted to alveolar epithelial ceils bordering 
connective tissue. These areas are characterized by a higher 
proliferative rate before entering the differentiation phase 
(18). In contrast, during functional differentiation in the lac- 
tating gland, MDGI transcripts were found predominantly in 
epithelial cells lining the terminal part of ducts.  We have 
shown earlier that during differentiation MDGI mRNA in- 
creases about fivefold comprising 0.5-0.8% of total mRNA 
in lactation (42). 
In summary, the data suggest that MDGI transcription is 
related to some functional role of MDGI in the onset of  early 
differentiation  which is coupled to inhibition of  cell prolifer- 
ation. In this respect, we found that injection of lactogenic 
hormones known to induce differentiation  increase the MDGI 
mRNA level in hypophysectomized rats (Kurtz, A., unpub- 
lished results). The appearance of MDGI transcripts in em- 
bryonic mammary epithelium also indicates a hormonal reg- 
ulation of MDGI expression. 
The apparent close parallel between expression of MDGI 
and of its mRNA during normal development of the bovine 
mammary gland suggest that transcriptional control mecha- 
Figure 7. Immunolabeling  of epithelial cells of mammary glands in different functional states. Lowicryl K4M embedded sections of virgin 
(A), pregnant (B), and lactating (C) animals were incubated with anti-MDGI-IgG. Sections of terminally differentiated epithelial cells 
of lactating glands were also analyzed with anti-p69/78-IgG (D) and anti-pl21/131-IgG (E). Euchromatin (ECh), heterochromatin (HCh), 
rnitochondria (M), endoplasmic reticulum (ER, RER), basal lamina (BL), cytoplasma (Cy). Bars, 1 ~m. 
The Journal of Cell Biology,  Volume 110, 1990  1786 Kurtz et al. MDGI Erpression in the Mammary Gland  1787 nisms are a major regulator.  Taking into account our finding 
of a chromatin-associated MDGI-form (42) it is intriguing to 
speculate that under conditions of an increased MDGI syn- 
thesis in mammary epithelial cells entering differentiation, 
MDGI is directly involved in gene expression. The availabil- 
ity of the MDGI cDNA will now make it possible to define 
more exactly the role of MDGI during the development of 
mammary gland by performing expression studies coupled 
with site-directed mutagenesis. 
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